Viral detection using a multiplex polymerase chain reaction–based assay in outpatients with upper respiratory infection()

We evaluated a commercial multiplex polymerase chain reaction (PCR) assay in a cross-sectional study among 81 adult and pediatric outpatients—40 cases with upper respiratory infection symptoms and 41 asymptomatic controls—from February to April 2008. Two specimens (throat swab and nasal swab) from e...

Descripción completa

Detalles Bibliográficos
Autores principales: Leekha, Surbhi, Irish, Cole L., Schneider, Susan K., Fernholz, Emily C., Espy, Mark J., Cunningham, Scott A., Patel, Robin, Juhn, Young J., Pritt, Bobbi, Smith, Thomas F., Sampathkumar, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2013
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127585/
https://www.ncbi.nlm.nih.gov/pubmed/23182565
http://dx.doi.org/10.1016/j.diagmicrobio.2012.10.016
Descripción
Sumario:We evaluated a commercial multiplex polymerase chain reaction (PCR) assay in a cross-sectional study among 81 adult and pediatric outpatients—40 cases with upper respiratory infection symptoms and 41 asymptomatic controls—from February to April 2008. Two specimens (throat swab and nasal swab) from each participant were tested using the EraGen MultiCode-PLx Respiratory Virus Panel that detects 17 viral targets. Throat swabs were also tested for Group A Streptococcus (GAS) by PCR. Respiratory viruses were detected in 22/40 (55%) cases and in 3/41 (7%) controls (P < 0.001). GAS was detected in 10 (25%) cases; GAS and respiratory virus co-infection was found in 4 (10%). Agreement between nasal and throat swabs for viral detection was 69% in cases and 95% in controls. Of 22 cases with a detectable virus, 12 (54%) were picked up by only 1 (throat or nasal) specimen, and the detection rate was increased by combining results of nasal and throat swab testing.

Ejemplares similares